Preliminary experiments show conolidine may possibly inhibit unique ion channels, reducing neuronal excitability and limiting discomfort indicators. This mechanism is particularly pertinent in neuropathic pain, wherever abnormal signaling triggers persistent distress. Additionally, conolidine se